The authors relay the outcome of a two-day workshop that brought together regulators and generic-drug industry representatives.
Robert Lionberger
Advertisement
Robert Lionberger is a chemist at the Office of Generic Drugs at the US Food and Drug Administration.
Articles by Robert Lionberger
Advertisement
Latest Updated Articles
Quality by Design for Generic DrugsPublished: October 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Challenges for the Global Manufacturing of Vaccines
5
